Berkshire Sterile Manufacturing, LLC, headquartered in the United States, is a leading player in the contract manufacturing industry, specialising in sterile fill-finish services for biopharmaceuticals. Founded in 2015, the company has rapidly established itself as a trusted partner for clients seeking high-quality, aseptic production solutions. With a focus on innovation and compliance, Berkshire Sterile Manufacturing offers a range of core services, including vial filling, syringe filling, and lyophilisation, all tailored to meet the stringent requirements of the pharmaceutical sector. The company’s state-of-the-art facilities and commitment to quality assurance set it apart in a competitive market. Recognised for its exceptional service and operational excellence, Berkshire Sterile Manufacturing continues to expand its footprint, serving clients across North America and beyond, while maintaining a strong reputation for reliability and expertise in sterile manufacturing.
How does Berkshire Sterile Manufacturing, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Berkshire Sterile Manufacturing, LLC's score of 67 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Berkshire Sterile Manufacturing, LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Inizio Group Limited, which influences its climate commitments and emissions reporting. As part of its corporate family, Berkshire Sterile Manufacturing inherits climate initiatives and targets from Inizio Group Limited, which operates at a cascade level of 3. However, there are no documented reduction targets or specific climate pledges outlined for Berkshire Sterile Manufacturing at this time. The absence of emissions data and reduction initiatives suggests that the company may still be in the early stages of formalising its climate strategy. As the industry increasingly prioritises sustainability, it is essential for Berkshire Sterile Manufacturing to establish clear emissions reduction goals and commitments to align with broader climate action efforts.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 22,734,000 | 0,000,000 | 00,000,000 | - | - |
| Scope 2 | 11,122,000 | 0,000,000 | 0,000,000 | - | - |
| Scope 3 | 1,173,000 | 00,000,000 | 00,000,000 | - | - |
Berkshire Sterile Manufacturing, LLC's Scope 3 emissions, which increased by 114% last year and increased significantly since 2019, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 72% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 66% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Berkshire Sterile Manufacturing, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.